SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5/A - Annual statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-23-008514
Filing Date
2023-02-06
Accepted
2023-02-06 17:39:14
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 5/A  
1 OWNERSHIP DOCUMENT ownership.xml 5/A 18569
  Complete submission text file 0001213900-23-008514.txt   20013
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 138 CANTERBURY LN BLUE BELL PA 19422
Business Address
TRAVERSA SERGIO (Reporting) CIK: 0001565832 (see all company filings)

Type: 5/A | Act: 34 | File No.: 001-39082 | Film No.: 23591752